Business

Japan approves Sanofi’s subcutaneous Sarclisa for myeloma

Jun 19, 2026 - 12:01
 1
Japan approves Sanofi’s subcutaneous Sarclisa for myeloma
Read More

Related Posts

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corp...

Mar 21, 2025  4

Argentina suspends Telecom's purchase of Telefonica unit

Argentina suspends Telecom's purchase of Telefonica unit

Mar 21, 2025  2

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025  3

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025  5

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025  6

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0